Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Apollo Therapeutics and Oxford University Partnership LAUNCH

Recently the University of Oxford signed a partnership with Apollo Therapeutics. Further details of this collaboration can be found on the University News.  Apollo Therapeutics – a biopharmaceutical portfolio company -  will work closely with the University of Oxford to help its academics translate their research into novel, first-in-class therapeutics for patients.  The collaboration aims to de-risk and accelerate the development of academic research ideas along the translation pathway. The range of therapeutics Apollo are interested in is fairly broad, spanning small molecules, biologics and vaccines. Additionally, the stage at which Apollo seek to engage with research is similarly broad, and encompasses early target discovery and validation through to clinical trials. The company are disease agnostic.

We are running a University of Oxford/Apollo Therapeutics Launch event on Wednesday 4 December 15:30 – 17:30 at the Divinity School, Oxford.

Please complete this form or  get in touch with Elizabeth.covey-crump@medsci.ox.ac.uk if you would like to attend this event. In addition, if you would like an informal meeting to discuss your research with Apollo please get in touch”

On this page